Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Clasificación en acciones #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Precio por acción
$0.00156481
Última sincronización: 2024-06-05
Capitalización bursátil
$17.03K
Cambio (1 día)
2.11%
Cambio (1 año)
0.00%
País
GB
Comercio Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Categoría

Ratio P/S de Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Oxford Cannabinoid Technologies Holdings Plc, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Oxford Cannabinoid Technologies Holdings Plc desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE